trending Market Intelligence /marketintelligence/en/news-insights/trending/1hLBbKbWtJxeE7JfDwqqQA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Sagittarius Life Science Q3 profit climbs YOY

Blog

Minimizing Risk at a Bank with a Trade Intelligence Platform

Blog

2021 US broadband forecast lifted by rising digital home profiles

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

Latin American and Caribbean Market Considerations Blog Series: Focus on IFRS 9


Sagittarius Life Science Q3 profit climbs YOY

Sagittarius Life Science Corp. said its normalized net income for the third quarter was NT$2.20 per share, a gain from 6 cents per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was NT$68.0 million, a gain from NT$1.7 million in the year-earlier period.

The normalized profit margin climbed to 19.3% from 1.4% in the year-earlier period.

Total revenue grew year over year to NT$352.4 million from NT$122.7 million, and total operating expenses grew year over year to NT$269.9 million from NT$121.7 million.

Reported net income grew from the prior-year period to NT$104.8 million, or NT$3.40 per share, from NT$2.3 million, or 9 cents per share.

As of Nov. 16, US$1 was equivalent to NT$32.83.